Brief: Dr. Lal Pathlabs Says NCLT Sanctions Scheme Of Amalgamation Between Co, Delta Ria And Pathology
26/10/2018 13:37
Oct 26 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* DR. LAL PATHLABS - NCLT SANCTIONS SCHEME OF AMALGAMATION
BETWEEN
CO AND DELTA RIA AND PATHOLOGY PRIVATE LIMITED
Source text for Eikon: ID:nBSE3PL42p
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise